JP2002500177A5 - - Google Patents

Download PDF

Info

Publication number
JP2002500177A5
JP2002500177A5 JP2000527230A JP2000527230A JP2002500177A5 JP 2002500177 A5 JP2002500177 A5 JP 2002500177A5 JP 2000527230 A JP2000527230 A JP 2000527230A JP 2000527230 A JP2000527230 A JP 2000527230A JP 2002500177 A5 JP2002500177 A5 JP 2002500177A5
Authority
JP
Japan
Prior art keywords
carbon
particles
variants
iron
particle
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2000527230A
Other languages
English (en)
Japanese (ja)
Other versions
JP2002500177A (ja
Filing date
Publication date
Priority claimed from US09/003,286 external-priority patent/US6200547B1/en
Application filed filed Critical
Publication of JP2002500177A publication Critical patent/JP2002500177A/ja
Publication of JP2002500177A5 publication Critical patent/JP2002500177A5/ja
Pending legal-status Critical Current

Links

JP2000527230A 1998-01-06 1999-01-06 磁気応答性組成物 Pending JP2002500177A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US09/003,286 US6200547B1 (en) 1994-01-26 1998-01-06 Magnetically responsive compositions for carrying biologically active substances and methods of production and use
US09/003,286 1998-01-06
PCT/US1999/000243 WO1999034779A1 (en) 1998-01-06 1999-01-06 Magnetically responsive composition

Publications (2)

Publication Number Publication Date
JP2002500177A JP2002500177A (ja) 2002-01-08
JP2002500177A5 true JP2002500177A5 (enExample) 2006-03-02

Family

ID=21705076

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2000527230A Pending JP2002500177A (ja) 1998-01-06 1999-01-06 磁気応答性組成物

Country Status (11)

Country Link
US (1) US6200547B1 (enExample)
EP (1) EP1043975A4 (enExample)
JP (1) JP2002500177A (enExample)
KR (1) KR20010024836A (enExample)
CN (1) CN1348362A (enExample)
AU (1) AU744205B2 (enExample)
BR (1) BR9906786A (enExample)
CA (1) CA2317019C (enExample)
IL (2) IL137033A (enExample)
NZ (1) NZ505408A (enExample)
WO (1) WO1999034779A1 (enExample)

Families Citing this family (47)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6482436B1 (en) * 1993-01-29 2002-11-19 Ferx Incorporated Magnetically responsive composition
WO2001066139A1 (en) * 2000-03-06 2001-09-13 University Of Kentucky Research Foundation Use of a compound that selectively binds to cd123 to impair hematologic cancer progenitor cell
US6488615B1 (en) 2000-03-31 2002-12-03 Ferx Incorporated Permanent magnet keeper-shield assembly
US7090636B2 (en) * 2000-03-31 2006-08-15 Fe Rx Incorporated Permanent magnet keeper-shield assembly
US7863011B2 (en) * 2000-05-10 2011-01-04 Signe Biopharma, Inc. Screening method for predicting susceptibility to breast cancer
US8119138B2 (en) * 2000-05-10 2012-02-21 Signe Biopharma Inc. Anti-estrogen and immune modulator combinations for treating breast cancer
US7947275B2 (en) 2000-05-10 2011-05-24 Signe Biopharma, Inc. Compositions and methods for demonstrating secretory immune system regulation of steroid hormone responsive cancer cell growth
US20030072812A1 (en) 2001-05-10 2003-04-17 Sirbasku David A Breast cancer eradication program
US6921283B2 (en) * 2001-08-27 2005-07-26 Trompeter Electronics, Inc. BNC connector having visual indication
US6679827B2 (en) * 2001-10-11 2004-01-20 Robert E. Sandstrom Magnetic field enhancement of tumor treatment
WO2003042404A2 (en) * 2001-11-13 2003-05-22 Sirbasku David A Breast cancer eradication program
US7249604B1 (en) 2002-05-10 2007-07-31 Vasmo, Inc. Medical devices for occlusion of blood flow
CN100384475C (zh) * 2002-10-29 2008-04-30 德州科隆载体研究所 磁引导抗癌药剂的制备方法
CA2549994A1 (en) * 2002-12-18 2004-08-12 Hough Ear Institute Otologic nanotechnology
US20050261763A1 (en) * 2003-04-08 2005-11-24 Xingwu Wang Medical device
US20050278020A1 (en) * 2003-04-08 2005-12-15 Xingwu Wang Medical device
US20050155779A1 (en) * 2003-04-08 2005-07-21 Xingwu Wang Coated substrate assembly
US20050025797A1 (en) * 2003-04-08 2005-02-03 Xingwu Wang Medical device with low magnetic susceptibility
US20050244337A1 (en) * 2003-04-08 2005-11-03 Xingwu Wang Medical device with a marker
US20050240100A1 (en) * 2003-04-08 2005-10-27 Xingwu Wang MRI imageable medical device
US7723311B2 (en) * 2003-06-18 2010-05-25 Nanobiomagnetics, Inc. Delivery of bioactive substances to target cells
US7344491B1 (en) 2003-11-26 2008-03-18 Nanobiomagnetics, Inc. Method and apparatus for improving hearing
US8651113B2 (en) * 2003-06-18 2014-02-18 Swr&D Inc. Magnetically responsive nanoparticle therapeutic constructs and methods of making and using
DE10359252A1 (de) * 2003-12-17 2005-07-28 Siemens Ag Navigierte Wärmebehandlung von Tumoren mit enzymumhüllten Eisenpartikeln
US20070027532A1 (en) * 2003-12-22 2007-02-01 Xingwu Wang Medical device
US8562505B2 (en) * 2004-02-20 2013-10-22 The Children's Hospital Of Philadelphia Uniform field magnetization and targeting of therapeutic formulations
US9028829B2 (en) * 2004-02-20 2015-05-12 The Children's Hospital Of Philadelphia Uniform field magnetization and targeting of therapeutic formulations
US7846201B2 (en) * 2004-02-20 2010-12-07 The Children's Hospital Of Philadelphia Magnetically-driven biodegradable gene delivery nanoparticles formulated with surface-attached polycationic complex
US20070100457A1 (en) * 2004-03-04 2007-05-03 Hyde Edward R Jr Paramagnetic liquid interface
GB0405552D0 (en) * 2004-03-12 2004-04-21 Magnet Attraction Ltd Methods for the targetted delivery of biological molecules
WO2005110395A1 (en) * 2004-05-19 2005-11-24 University Of South Carolina System and device for magnetic drug targeting with magnetic drug carrier particles
WO2006002365A2 (en) * 2004-06-24 2006-01-05 Angiotech International Ag Microparticles with high loadings of a bioactive agent
CN1733314A (zh) * 2004-08-11 2006-02-15 张阳德 半乳糖化白蛋白磁性阿霉素纳米粒的制备方法
US20100259259A1 (en) * 2005-09-21 2010-10-14 Markus Zahn Systems and methods for tuning properties of nanoparticles
US20070255086A1 (en) * 2006-04-26 2007-11-01 Nehls Robert J Medical Device Including Magnetic Particles
WO2008127735A1 (en) 2007-04-13 2008-10-23 Stemline Therapeutics, Inc. Il3ralpha antibody conjugates and uses thereof
US9034387B2 (en) * 2007-10-03 2015-05-19 Jawaharlal Nehru Centre For Advanced Scientific Research Intrinsically fluorescent carbon nanospheres and a process thereof
US20090169484A1 (en) 2007-12-28 2009-07-02 Ihi Corporation Iron-salen complex
JP2009274962A (ja) * 2008-05-12 2009-11-26 Yoshihiro Ishikawa 鉄サレン錯体、磁性を有する薬剤、薬剤の誘導システム、並びに磁気検出装置
CN102239138A (zh) 2008-11-20 2011-11-09 株式会社Ihi 自磁性金属salen络合物
US8740872B2 (en) 2010-10-19 2014-06-03 The Board Of Regents Of The University Of Oklahoma Magnetically-targeted treatment for cardiac disorders
US10398668B2 (en) 2010-10-19 2019-09-03 The Board Of Regents Of The University Of Oklahoma Glutamate treatment of cardiovascular disorders
US9744235B2 (en) 2010-10-19 2017-08-29 The Board Of Regents Of The University Of Oklahoma Treatment of cardiovascular disorders with targeted nanoparticles
JP2012176905A (ja) * 2011-02-25 2012-09-13 Ihi Corp 金属サレン錯体化合物
RU2546663C2 (ru) 2010-12-21 2015-04-10 АйЭйчАй КОРПОРЕЙШН Комплексное соединение металл-сален и способ его получения
JP2023538814A (ja) * 2020-08-13 2023-09-12 マツクス－プランク－ゲゼルシヤフト ツール フエルデルング デル ヴイツセンシヤフテン エー フアウ 送達デバイス
WO2025118073A1 (en) * 2023-12-04 2025-06-12 Rocket Science Health Corp. Magnetic formulations for biomarker sampling and enhanced drug delivery

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3718594A (en) 1970-11-30 1973-02-27 Eastman Kodak Co Method of preparing magnetically responsive carrier particles
US4106488A (en) 1974-08-20 1978-08-15 Robert Thomas Gordon Cancer treatment method
US4247406A (en) 1979-04-23 1981-01-27 Widder Kenneth J Intravascularly-administrable, magnetically-localizable biodegradable carrier
US4345588A (en) 1979-04-23 1982-08-24 Northwestern University Method of delivering a therapeutic agent to a target capillary bed
US4331654A (en) 1980-06-13 1982-05-25 Eli Lilly And Company Magnetically-localizable, biodegradable lipid microspheres
US4501726A (en) 1981-11-12 1985-02-26 Schroeder Ulf Intravascularly administrable, magnetically responsive nanosphere or nanoparticle, a process for the production thereof, and the use thereof
US4652257A (en) 1985-03-21 1987-03-24 The United States Of America As Represented By The Secretary Of The Navy Magnetically-localizable, polymerized lipid vesicles and method of disrupting same
US4849209A (en) 1985-06-07 1989-07-18 Cadema Medical Products, Inc. Treatment of arthritis, including rheumatoid arthritis with 166 Holmium radionuclide
US4818614A (en) 1985-07-29 1989-04-04 Shiseido Company Ltd. Modified powder
US4690130A (en) 1985-12-19 1987-09-01 Mirell Stuart G Electromagnetic therapy control system
US4871716A (en) 1986-02-04 1989-10-03 University Of Florida Magnetically responsive, hydrophilic microspheres for incorporation of therapeutic substances and methods of preparation thereof
JPH01122037U (enExample) 1988-02-12 1989-08-18
SU1722256A3 (ru) 1989-11-02 1992-03-23 Viktor A Volkonskij Cпocoб пoлучehия maгhиtoупpabляemoй диcпepcии
AU6165394A (en) * 1993-01-29 1994-08-15 Magnetic Delivered Therapeutics, Inc. Magnetically responsive composition for carrying biologically active substances and methods of production and use
US5776925A (en) * 1996-01-25 1998-07-07 Pharmacyclics, Inc. Methods for cancer chemosensitization
US5827533A (en) * 1997-02-06 1998-10-27 Duke University Liposomes containing active agents aggregated with lipid surfactants

Similar Documents

Publication Publication Date Title
JP2002500177A5 (enExample)
NZ505408A (en) Magnetically responsive composition, comprising ferrocarbon and a biologically active substance
HUP0000714A3 (en) New formulation for inhalation having a poured bulk density of 0.28 to 0.38 g/ml, a process for preparing the formulation and the use thereof
JP2002519061A5 (enExample)
DE60117047D1 (de) Kohlenstoffblock-wasserfilter
EP1161860A3 (en) Animal excretions-treating material capable of being disposed of in flush toilets
DE69201260D1 (de) Trennungsfreie Gaserzeugungszusammensetzung, bestehend aus lose aufgehäuften azidhaltige Pellets und dazwischen angeordneten kleinen silikatischen Partikel.
PT1418890E (pt) Formulações de micropartículas à base de propulsor
JP2003510764A5 (ja) 改変されたリチウムバナジウム酸化物電極材料およびその材料から製造された製品
GB9126924D0 (en) Composition for use in oral cavity
EP1219459A3 (en) Ink-jet recording material
EE9900320A (et) Uus inhaleeritav budesoniidi sisaldav ravimvorm puistetihedusega 0,28 kuni 0,38 g/ml
JP2001513504A5 (enExample)
DE50105761D1 (de) Stabilisierter roter Phosphor und ein Verfahren zu seiner Herstellung
JP2002537405A5 (enExample)
JP2000279802A5 (enExample)
NL1008020A1 (nl) Nieuwe formulering voor inhalatie.
TW200517504A (en) Producing method of sintered ore, producing method of material for sintered ore, agglomerated particle and sintered ore
JPH1017388A5 (enExample)
JPS5513153A (en) Ion adsorbent consisting of magnetic hydrous iron oxide
WO2000037546A3 (de) Expandierte polypropylen-partikel
JPH10194953A5 (enExample)
JPH1088060A5 (enExample)
JPS6440969A (en) Developer bearing body
JPH1091786A5 (enExample)